OTC Stocks With Big Potential: WHSI, HMNU, CGLD, CBDD, NTRR, WDLF

October 7, 2022

This is the last day of the trading week but that does not mean there is going to be any let up in the eagerness of investors when it comes to discovering the next stock worth tracking. There are hundreds of stocks that attract considerable attention from investors every day but it is not possible for an investor to keep track of all those stocks on any given day. Hence,…


Must See Penny Stock Watchlist: SHNJF, MMMM, NTRR, NWBO, BMIX, UNRV

Penny stocks have almost always enjoyed a degree of popularity among a vast number of investors and for good reason. These stocks are generally available for less than $5 a share and hence, it allows an investor to acquire a large block of shares at any given point in time. If the stocks move upward then it is possible for investors to make handsome profits for low outlays. However, it…

July 7, 2022

Neutra Corp (OTCMKTS:NTRR) Stock Sees Further Selling Pressure After The News

November 11, 2021

Shares of Neutra Corp (OTCMKTS:NTRR) continued to trend in the previous trading session after the recent fall. Trading Data On Wednesday, NTRR stock fell 4.20% at $0.0023 with more than 5.20 million shares, compared to its average volume of 20.75 million shares. The stock has moved within a range of $0.0023 – 0.0027 after opening the trade at $0.0025. “Booming Interest” in Sales after Texas Judge Issues Injunction Making Delta-8…


VIVIS, a subsidiary of Neutra Corp (NTRR) Stock Extends Rally: Jumps 47% in a Week

September 14, 2021

VIVIS, a subsidiary of Neutra Corp (OTCMKTS:NTRR), has signed a letter of intent (LOI) with a clinical research company in Houston that would enable them to test hemp-based cannabinoids for the treatment of COVID-19. VIVIS plans to work with Mercury Clinical Research to start phase 1 clinical trials on the efficacy of CBD in treating SARS-COVID-2. They might also use the trials to find other uses of ant-inflammation,appetite suppressant, anti-insomnia,…